Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
neuronal cell adhesion molecule | 0.666 | 0.423 | 1.5E-02 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2008 | 2011 | ||||||||
|
spectrin repeat containing nuclear envelope protein 1 | 0.511 | 0.846 | 3.2E-52 |
|
disease | 0.530 | None | 1.000 | 2 | 3 | 2008 | 2015 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
disease | 0.400 | None | 0.958 | 2 | 0 | 2004 | 2018 | ||||||||
|
secreted frizzled related protein 2 | 0.544 | 0.731 | 1.7E-03 |
|
disease | 0.400 | None | 0.963 | 2 | 0 | 2004 | 2019 | ||||||||
|
CD109 molecule | 0.595 | 0.654 | 2.3E-44 |
|
disease | 0.500 | None | 1.000 | 2 | 1 | 2008 | 2011 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.991 | 2 | 0 | 1992 | 2020 | ||||||||
|
gremlin 1, DAN family BMP antagonist | 0.508 | 0.808 | 0.47 |
|
disease | 0.500 | None | 0.957 | 2 | 4 | 2003 | 2019 | ||||||||
|
uridine monophosphate synthetase | 0.584 | 0.615 | 1.1E-04 |
|
disease | 0.330 | None | 1.000 | 2 | 0 | 2005 | 2013 | ||||||||
|
Enah/Vasp-like | 0.729 | 0.308 | 1.00 |
|
disease | 0.520 | None | 1.000 | 2 | 1 | 2008 | 2015 | ||||||||
|
DNA polymerase delta 3, accessory subunit | 0.631 | 0.462 | 1.00 |
|
disease | 0.420 | None | 1.000 | 2 | 3 | 2012 | 2019 | ||||||||
|
leucine rich repeat containing G protein-coupled receptor 6 | 0.502 | 0.923 | 2.9E-06 |
|
disease | 0.520 | None | 1.000 | 2 | 0 | 2008 | 2018 | ||||||||
|
DNA polymerase epsilon, catalytic subunit | 0.526 | 0.731 | 8.0E-27 |
|
disease | 0.600 | strong | 1.000 | 2 | 0 | 2013 | 2020 | ||||||||
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase | 0.502 | 0.808 | 2.2E-14 |
|
disease | 0.390 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
disease | 0.600 | None | 1.000 | 2 | 0 | 2008 | 2019 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
disease | 0.500 | None | 0.939 | 2 | 2 | 1997 | 2020 | ||||||||
|
StAR related lipid transfer domain containing 8 | 0.743 | 0.346 | 2.5E-02 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2008 | 2011 | ||||||||
|
intercellular adhesion molecule 5 | 0.716 | 0.346 | 2.1E-03 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2008 | 2011 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2006 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.600 | None | 0.960 | 2 | 0 | 1990 | 2020 | ||||||||
|
ATP binding cassette subfamily A member 12 | 0.610 | 0.654 | 2.9E-15 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
alpha-methylacyl-CoA racemase | 0.510 | 0.769 | 2.7E-02 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2002 | 2015 | ||||||||
|
NME/NM23 nucleoside diphosphate kinase 1 | 0.443 | 0.808 | 3.2E-03 |
|
disease | 0.400 | None | 0.885 | 1 | 0 | 1991 | 2018 | ||||||||
|
calcium binding tyrosine phosphorylation regulated | 0.792 | 0.192 | 2.3E-06 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
secreted frizzled related protein 4 | 0.524 | 0.654 | 9.3E-05 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2006 | 2010 | ||||||||
|
glyceraldehyde-3-phosphate dehydrogenase | 0.447 | 0.808 | 0.11 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2006 | 2019 |